These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20112186)

  • 1. Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children.
    Marte A; Borrelli M; Sabatino MD; Balzo BD; Prezioso M; Pintozzi L; Nino F; Parmeggiani P
    Eur J Pediatr Surg; 2010 May; 20(3):153-7. PubMed ID: 20112186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection.
    Lucioni A; Rapp DE; Gong EM; Fedunok P; Bales GT
    Can J Urol; 2006 Oct; 13(5):3291-5. PubMed ID: 17076955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor.
    Hoebeke P; De Caestecker K; Vande Walle J; Dehoorne J; Raes A; Verleyen P; Van Laecke E
    J Urol; 2006 Jul; 176(1):328-30; discussion 330-1. PubMed ID: 16753434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity.
    Sahai A; Dowson C; Khan MS; Dasgupta P;
    Urology; 2010 Mar; 75(3):552-8. PubMed ID: 20035984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin type A in patients with overactive bladder].
    Krivoborodov GG; Vasil'ev AV; Shumilo DV; Ivanov AV; Tur EI
    Urologiia; 2010; (3):36-40. PubMed ID: 20734876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
    Kajbafzadeh A; Mahboubi AH; Payabvash S
    BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with injections of botulinum toxin type A into the detrusor muscle.
    Miyagawa I; Watanabe T; Isoyama T; Honda M; Kobayasi N; Hikita K; Saito M; Hirakawa S
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S24-6. PubMed ID: 20094947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.
    Cohen BL; Rivera R; Barboglio P; Gousse A
    J Urol; 2007 Mar; 177(3):1006-10; discussion 1010. PubMed ID: 17296397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?
    Kuo HC
    Urology; 2006 Nov; 68(5):993-7; discussion 997-8. PubMed ID: 17113890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2008 Feb; 101(4):515-6; author reply 516-7. PubMed ID: 18234066
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged urinary retention after intravesical botulinum injection for treatment of idiopathic detrusor overactivity.
    King AB; Rapp DE
    Can J Urol; 2011 Apr; 18(2):5657-9. PubMed ID: 21504656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity.
    Schulte-Baukloh H; Knispel HH; Stolze T; Weiss C; Michael T; Miller K
    Urology; 2005 Oct; 66(4):865-70; discussion 870. PubMed ID: 16230156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder].
    Bentaleb Y; Castel-Lacanal E; Sallusto F; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
    Prog Urol; 2008 Jul; 18(7):449-55. PubMed ID: 18602606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.
    White WM; Pickens RB; Doggweiler R; Klein FA
    J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.
    Schulte-Baukloh H; Weiss C; Stolze T; Herholz J; Stürzebecher B; Miller K; Knispel HH
    Eur Urol; 2005 Dec; 48(6):984-90; discussion 990. PubMed ID: 16126328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.